A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail*
Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: British Journal of Dermatology
DOI: 10.1111/bjd.19224
Authors: B. Elewski, S. Brand, T. Degenhardt, S. Curelop, R. Pollak, R. Schotzinger, A. Tavakkol, Javier Alonso‐Llamazares, Scott J. Ashton, Neal Bhatia, Michael Billings, Andrew Blauvelt, Norman Bystol, Brandt Dodson, Michael H. Gold, Kimberly Grande, Michael Jarratt, Terry S. Jones, Maria A. Kasper, Steven E. Kempers, Brock McConnehey, Michael Noss, David Pariser, Lawrence Parish, Phoebe Rich, Joseph Ahmad Samady, Joel Schlessinger, Doug Schumacher, Kenneth Stein, Cynthia Strout, Eduardo Tschen, John H. Tu, Max Weisfeld
Language: English
Topic: Nail Diseases and Treatments
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3026274121